methacholine PC20
Showing 1 - 25 of 5,835
Asthma Trial in Hamilton (Dupilumab/Dupixent, Placebo)
Recruiting
- Asthma
- Dupilumab/Dupixent
- Placebo
-
Hamilton, Ontario, CanadaFirestone Institute for Respiratory Health, St. Joseph's Healthc
Sep 6, 2021
Asthma Atopic Trial in Chapel Hill (Felis Catus)
Terminated
- Asthma Atopic
- Felis Catus
-
Chapel Hill, North CarolinaKatie Mills
Sep 22, 2022
FEV1 and IOS Parameters in Adult Asthma Patients
Not yet recruiting
- Bronchial Hyperreactivity
- No intervention
- (no location specified)
Sep 12, 2023
Primary Immunodeficiency Trial in United States (IGSC 20%)
Completed
- Primary Immunodeficiency
- IGSC 20%
-
Birmingham, Alabama
- +11 more
Nov 2, 2022
Methacholine Choline Provocation Test in Asthmatic Population
Recruiting
- Asthma
- Methacholine Choline Provocation Test
-
Beijing, Beijing, China
- +5 more
May 22, 2023
Post-COVID-19 Syndrome Trial in Kiel, Tuebingen, Würzburg (Prednisolone 20 mg/ 5 mg, Vitamin B compound (100mg B1, 50 mg B6, 500
Recruiting
- Post-COVID-19 Syndrome
- Prednisolone 20 mg/ 5 mg
- +3 more
-
Kiel, Germany
- +2 more
Dec 1, 2022
Bronchial Asthma Trial in Medford (Albuterol Sulfate Inhalation Aerosol (90 mcg per actuation), Ventolin HFA 90Mcg/Actuation
Not yet recruiting
- Bronchial Asthma
- Albuterol Sulfate Inhalation Aerosol (90 mcg per actuation)
- +3 more
-
Medford, OregonVelocity CLinical Research
Nov 23, 2023
Asthma Trial in Boston (coconut oil)
Not yet recruiting
- Asthma
- coconut oil
-
Boston, MassachusettsAsthma Research Center, Brigham and Women's Hospital
Oct 7, 2022
Asthma Trial in Erpent (AQ001S 0.125 mg/ml, Budesonide 0.125 mg/ml inhalation suspension)
Recruiting
- Asthma
- AQ001S 0.125 mg/ml
- Budesonide 0.125 mg/ml inhalation suspension
-
Erpent, Namur, BelgiumPneumocare SPRL
Nov 2, 2022
Asthma Trial in China (Methacholine Chloride)
Not yet recruiting
- Asthma
- Methacholine Chloride
-
Beijing, Beijing, China
- +11 more
Dec 1, 2022
Asthma Trial in Hamilton, Sainte-Foy (Quebec City), Saskatoon (Nebulized IVX-0142)
Completed
- Asthma
- Nebulized IVX-0142
-
Hamilton, Ontario, Canada
- +2 more
Nov 5, 2021
Mild Asthma Trial in New Taipei City (Albuterol Sulfate inhalation aerosol 108 mcg per actuation, Proair HFA (Albuterol Sulfate)
Not yet recruiting
- Mild Asthma
- Albuterol Sulfate inhalation aerosol 108 mcg per actuation
- +4 more
-
New Taipei City, TaiwanClinical Pharmacology Unit,Mackay Memorial Hospital
Jun 3, 2021
MDD Trial in United States (XEN1101 10 mg, XEN1101 20 mg, Placebo)
Recruiting
- Major Depressive Disorder
- XEN1101 10 mg
- +2 more
-
Lafayette, California
- +5 more
Jul 11, 2022
Asthma, Allergic Trial in Hamilton, Saskatoon (Tezepelumab, Placebo)
Not yet recruiting
- Asthma, Allergic
- Tezepelumab
- Placebo
-
Hamilton, Ontario, Canada
- +1 more
Feb 22, 2023
Asthma Trial in Saskatoon (Tiotropium Bromide, Matching )
Completed
- Asthma
- Tiotropium Bromide
- Matching placebo
-
Saskatoon, Saskatchewan, CanadaAsthma Research Lab University of Saskatchewan Room 346 Ellis Ha
May 16, 2022
IL13 Signaling in Allergic Asthma
Not yet recruiting
- Asthma, Allergic
- +2 more
-
Durham, North CarolinaDuke Asthma Allergy and Airway Center
Jul 26, 2022
Spinal Stenosis Lumbar Trial in United States (coflex® Interlaminar Technology, Decompression)
Recruiting
- Spinal Stenosis Lumbar
- coflex® Interlaminar Technology
- Decompression
-
Durango, Colorado
- +9 more
Aug 23, 2022
Experimental Trial in Vancouver (Filtered Air Exposure, Diesel Exhaust Exposure)
Completed
- Experimental
- Filtered Air Exposure
- Diesel Exhaust Exposure
-
Vancouver, British Columbia, CanadaUniversity of British Columbia - VGH site
Oct 29, 2021
Asthma Trial in Hamilton (Wright jet nebulizer, Aerogen Solo)
Not yet recruiting
- Asthma
- Wright jet nebulizer
- Aerogen Solo
-
Hamilton, Ontario, CanadaMcMaster Cardio-Respiratory Research Lab
Nov 10, 2020
Asthma Trial in Tampere (Buventol® Easyhaler® 200 µg/inhalation dmDPI, Bufomix® Easyhaler® 160/4.5 µg/inhalation dmDPI,
Recruiting
- Asthma
- Buventol® Easyhaler® 200 µg/inhalation dmDPI
- +2 more
-
Tampere, FinlandTampere University Hospital
Oct 26, 2022
Cystic Fibrosis, Asthma, Severe Persistent Asthma Trial in Indianapolis, Cleveland (Glycine Buffer)
Recruiting
- Cystic Fibrosis
- +3 more
- Glycine Buffer
-
Indianapolis, Indiana
- +1 more
Feb 24, 2022
Asthma, Cough Variant Asthma Trial in Kingston (high-dose methacholine challenge test, mannitol challenge test)
Completed
- Asthma
- Cough Variant Asthma
- high-dose methacholine challenge test
- mannitol challenge test
-
Kingston, Ontario, CanadaKingston General Hospital
Feb 9, 2022